Skip to main content
. Author manuscript; available in PMC: 2014 May 15.
Published in final edited form as: Biol Psychiatry. 2013 Feb 26;73(10):1008–1014. doi: 10.1016/j.biopsych.2013.01.016

Table 2.

Endpoint analyses of outcome variables (following 15 sessions)1

Outcome variable mean (standard error)4 PGroup effect Estimated effect size (95% CI)
Sham N=28 Active N=55
HCS2 (primary) 7.78 (0.67) 6.38 (0.47) 0.09 0.40
Hallucination frequency difference3 −0.26 (0.31) −1.32 (0.22) 0.005 0.65 (0.19 – 1.11)
Total AHRS Difference3 −2.78 (1.2) −4.58 (0.85) 0.22 0.28
CGI2 3.31 (0.25) 2.70 (0.17) 0.045 0.47 (0.01 – 0.93)
1

Model includes group and site (W versus rW, corresponding to optimal response); based on data collected after the third 5-session block, with multiple imputations used for missing data

2

Lower scores correspond to greater improvement; all HCS were 10 at baseline; no baseline for CGI, scores range from 1 to 7, with 4 = no change.

3

Difference = baseline − endpoint; lower scores correspond to greater improvement

4

Model-based least-square means and standard errors